Baza Protect Cream
NDC Package 11701-082-22
Package Information
Baza Protect (zinc oxide and dimethicone) cream is apply to affected area and gently wipe with clean, soft cloth.Apply as needed, especially at bedtime or any time when exposure to moisture may be prolonged. This formulation utilizes a cream delivery system. Marketed by Coloplast Corp, this product is identified by NDC 11701-082 and is authorized under FDA application M016.
Identification & Billing
- RxCUI: 1053158 - Baza Protect 1 % / 12 % Topical Cream
- RxCUI: 1053158 - dimethicone 10 MG/ML / zinc oxide 120 MG/ML Topical Cream [Baza-Protect]
- RxCUI: 1053158 - Baza Protect (dimethicone 1 % / zinc oxide 12 % ) Topical Cream
- RxCUI: 1053158 - dimethicone 10 MG/ML / ZNO 120 MG/ML Topical Cream [Baza-Protect]
- RxCUI: 637565 - dimethicone 1 % / zinc oxide 12 % Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11701 - Coloplast Corp
- 11701-082 - Baza Protect
- 11701-082-22 - 4 g in 1 PACKET
- 11701-082 - Baza Protect
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (11701-082). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11701-082-22 identifies a specific commercial package of 4 g in 1 packet of Baza Protect, a human over the counter drug labeled by Coloplast Corp. This cream is formulated for topical use and contains dimethicone, unspecified; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Coloplast Corp on April 06, 2020. The current certification is valid through December 31, 2027.
How is this Coloplast Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11701008222. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.